Table 3.

Percentage change and inhibition in rat paw height after carrageenan-Induced paw edema in rats.

Compound	% Change in Paw Height (Mean ± SEM)			Anti-Inflammatory Activity (% Inhibition of Edema)
	1 hr	2 hr	3 hr	3 hr
Control	0.36 ± 0.01	0.44 ± 0.01	0.50 ± 0.01	---------
Diclofenac	0.15 ± 0.03 a	0.13 ± 0.02 a	0.20 ± 0.01 a	63
4a	0.49 ± 0.01 a	0.40 ± 0.02 a	0.49 ± 0.02 a	24
4b	0.47 ± 0.04 a	0.38 ± 0.03 a	0.47 ± 0.01 a	26
5a	0.45 ± 0.03 a	0.36 ± 0.02 a	0.46 ± 0.02 a	28
5b	0.42 ± 0.04 a	0.34 ± 0.01 a	0.44 ± 0.03 a	30
6a	0.39 ± 0.01 a	0.32 ± 0.02 a	0.41 ± 0.02 a	35
6b	0.38 ± 0.03 a	0.31 ± 0.04 a	0.39 ± 0.01 a	38
7a	0.31 ± 0.01 a	0.26 ± 0.02 a	0.30 ± 0.02 a	50
7b	0.30 ± 0.02 a	0.25 ± 0.01 a	0.29 ± 0.01 a	52
8a	0.37 ± 0.02 a	0.30 ± 0.03 a	0.37 ± 0.02 a	40
8b	0.36 ± 0.01 a	0.29 ± 0.02 a	0.35 ± 0.02 a	42
9a	0.35 ± 0.01 a	0.28 ± 0.02 a	0.33 ± 0.02 a	45
9b	0.33 ± 0.02 a	0.27 ± 0.01 a	0.31 ± 0.01 a	48
10a	0.19 ± 0.01 a	0.14 ± 0.02 a	0.16 ± 0.02 a	67
10b	0.21 ± 0.02 a	0.16 ± 0.01 a	0.18 ± 0.01 a	65
10c	0.18 ± 0.01 a	0.13 ± 0.02 a	0.15 ± 0.02 a	68
10d	0.20 ± 0.01 a	0.15 ± 0.02 a	0.17 ± 0.02 a	66
11a	0.30 ± 0.02 a	0.24 ± 0.01 a	0.28 ± 0.01 a	55
11b	0.29 ± 0.01 a	0.23 ± 0.01 a	0.27 ± 0.02 a	56
12a	0.28 ± 0.02 a	0.23 ± 0.01 a	0.26 ± 0.01 a	57
12b	0.28 ± 0.01 a	0.22 ± 0.02 a	0.25 ± 0.02 a	58
13a	0.27 ± 0.02 a	0.21 ± 0.01 a	0.24 ± 0.01 a	59
13b	0.23 ± 0.02 a	0.18 ± 0.01 a	0.20 ± 0.02 a	63
13c	0.25 ± 0.01 a	0.19 ± 0.02 a	0.22 ± 0.02 a	61
13d	0.26 ± 0.01 a	0.20 ± 0.02 a	0.23 ± 0.02 a	60
13e	0.22 ± 0.01 a	0.17 ± 0.02 a	0.19 ± 0.02 a	64
13f	0.24 ± 0.02 a	0.18 ± 0.02 a	0.21 ± 0.01 a	62

Values are expressed as mean ± SEM (n = 5). Data were analyzed using one-way ANOVA followed by a Bonferroni post hoc test. A p-value was considered significant if it was less than 0.05 compared to control; ^aSignificantly different from the control group; ^b Significantly different from the diclofenac group.